# FDA Inspection 1035761 - OneBlood, Inc. - November 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/9bf0668a-e19b-42e0-aace-ba3bdbfdbeea
Source feed: FDA_Inspections

> FDA Inspection 1035761 for OneBlood, Inc. on November 14, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1035761
- Company Name: OneBlood, Inc.
- Inspection Date: 2017-11-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253975 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/oneblood-inc/12778306-6fad-49d2-bdac-7f58a7375fbe)
- [FDA Inspection 1253975 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/oneblood-inc/469938d8-7a6b-4aa2-bbbb-50656ae4db09)
- [FDA Inspection 1146588 - 2021-07-06](https://www.keypedia.com/records/fda_inspections/oneblood-inc/190ed38e-6aaa-418b-a479-9284fcadd9e9)
- [FDA Inspection 971538 - 2016-04-27](https://www.keypedia.com/records/fda_inspections/oneblood-inc/b2093c7f-2816-40c9-8746-407ed10fe428)

Company: https://www.keypedia.com/companies/oneblood-inc/153922db-e318-4ad6-a24d-9e8852729188

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d